Understanding the place for GLP‐1RA therapy: Translating guidelines for treatment of type 2 diabetes into everyday clinical practice and patient selection
Year: 2021
Type: review
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.14500
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, type 2 diabetes, cardiovascular outcome trials, cardiovascular risk, patient selection, guideline implementation, glycemic control, weight loss, renal protection, macroalbuminuria, exenatide, liraglutide, semaglutide, dulaglutide, tirzepatide, drug safety and side effects
Open Access status: closed
Funder: Steno Diabetes Center Copenhagen
Award: G1630305306
OpenAlex ID: W3200932276
